Francisco Javier Rodríguez-Baena

Dr. Francisco Javier Rodríguez-Baena

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2012 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
JAJesús Arenas
Jesús Arenas
RNReindert Nijland
Reindert Nijland
FRFrancisco Javier Rodríguez-Baena
Francisco Javier Rodríguez-Baena
TBTom N. P. Bosma
Tom N. P. Bosma
JTJan Tommassen
Jan Tommassen
Summary: Neisseria meningitidis is a common and usually harmless inhabitant of the mucosa of the human nasopharynx, which, in rare cases, can cross the epithelial barrier and cause meningitis and sepsis. Biofilm formation favours the colonization of the host and the subsequent carrier state. Two different strategies of biofilm formation, either dependent or independent on extracellular DNA (eDNA), have been described for meningococcal strains. Here, we demonstrate that the autotransporter protease NalP, the expression of which is phase variable, affects eDNA‐dependent biofilm formation in N. meningitidis. The effect of NalP was found in biofilm formation under static and flow conditions and was dependent on its protease activity. Cleavage of the heparin‐binding antigen NhbA and the α‐peptide of IgA protease, resulting in the release of positively charged polypeptides from the cell surface, was responsible for the reduction in biofilm formation when NalP is expressed. Both NhbA and the α‐peptide of IgA protease were shown to bind DNA. We conclude that NhbA and the α‐peptide of IgA protease are implicated in biofilm formation by binding eDNA and that NalP is an important regulator of this process through the proteolysis of these surface‐exposed proteins.

10 August 2023 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
MRMarta Redondo-Muñoz
Marta Redondo-Muñoz
FRFrancisco Javier Rodríguez-Baena
Francisco Javier Rodríguez-Baena
PAPaula Aldaz
Paula Aldaz
ACAdriá Caballé-Mestres
Adriá Caballé-Mestres
VMVerónica Moncho-Amor
Verónica Moncho-Amor
IAImanol Arozarena
Imanol Arozarena
Resistance of melanoma to targeted therapy and immunotherapy is linked to metabolic rewiring. Here, we show that increased fatty acid oxidation (FAO) during prolonged BRAF inhibitor (BRAFi) treatment contributes to acquired therapy resistance in mice. Targeting FAO using the US Food and Drug Administration-approved and European Medicines Agency-approved anti-anginal drug ranolazine (RANO) delays tumour recurrence with acquired BRAFi resistance. Single-cell RNA-sequencing analysis reveals that RANO diminishes the abundance of the therapy-resistant NGFRhi neural crest stem cell subpopulation. Moreover, by rewiring the methionine salvage pathway, RANO enhances melanoma immunogenicity through increased antigen presentation and interferon signalling. Combination of RANO with anti-PD-L1 antibodies strongly improves survival by increasing antitumour immune responses. Altogether, we show that RANO increases the efficacy of targeted melanoma therapy through its effects on FAO and the methionine salvage pathway. Importantly, our study suggests that RANO could sensitize BRAFi-resistant tumours to immunotherapy. Since RANO has very mild side-effects, it might constitute a therapeutic option to improve the two main strategies currently used to treat metastatic melanoma.

1 May 2015 in Matrix Biology
Verified
Journal Article
Open access
JRJuan Carlos Rodríguez-Manzaneque
Juan Carlos Rodríguez-Manzaneque
RFRubén Fernández-Rodríguez
Rubén Fernández-Rodríguez
FRFrancisco Javier Rodríguez-Baena
Francisco Javier Rodríguez-Baena
MIM. Luisa Iruela-Arispe
M. Luisa Iruela-Arispe
ADAMTS (a disintegrin and metalloprotease with thrombospondin motifs) proteases comprise the most recently discovered branch of the extracellular metalloenzymes. Research during the last 15years, uncovered their association with a variety of physiological and pathological processes including blood coagulation, tissue repair, fertility, arthritis and cancer. Importantly, a frequent feature of ADAMTS enzymes relates to their effects on vascular-related phenomena, including angiogenesis. Their specific roles in vascular biology have been clarified by information on their expression profiles and substrate specificity. Through their catalytic activity, ADAMTS proteases modify rather than degrade extracellular proteins. They predominantly target proteoglycans and glycoproteins abundant in the basement membrane, therefore their broad contributions to the vasculature should not come as a surprise. Furthermore, in addition to their proteolytic functions, non-enzymatic roles for ADAMTS have also been identified expanding our understanding on the multiple activities of these enzymes in vascular-related processes.

25 September 2017 in Leukemia
Verified
Journal Article
Open access
PDF file
CPC Prieto
C Prieto
BLB López-Millán
B López-Millán
HHHeleia Roca Ho
Heleia Roca Ho
RSR W Stam
R W Stam
DRD Romero-Moya
D Romero-Moya
PMPablo Menendez
Pablo Menendez
Mixed-lineage leukemia (MLL)-rearranged (MLLr) infant B-cell acute lymphoblastic leukemia (iMLLr-B-ALL) has a dismal prognosis and is associated with a pro-B/mixed phenotype, therapy refractoriness and frequent central nervous system (CNS) disease/relapse. Neuron-glial antigen 2 (NG2) is specifically expressed in MLLr leukemias and is used in leukemia immunophenotyping because of its predictive value for MLLr acute leukemias. NG2 is involved in melanoma metastasis and brain development; however, its role in MLL-mediated leukemogenesis remains elusive. Here we evaluated whether NG2 distinguishes leukemia-initiating/propagating cells (L-ICs) and/or CNS-infiltrating cells (CNS-ICs) in iMLLr-B-ALL. Clinical data from the Interfant cohort of iMLLr-B-ALL demonstrated that high NG2 expression associates with lower event-free survival, higher number of circulating blasts and more frequent CNS disease/relapse. Serial xenotransplantation of primary MLL-AF4+ leukemias indicated that NG2 is a malleable marker that does not enrich for L-IC or CNS-IC in iMLLr-B-All. However, NG2 expression was highly upregulated in blasts infiltrating extramedullar hematopoietic sites and CNS, and specific blockage of NG2 resulted in almost complete loss of engraftment. Indeed, gene expression profiling of primary blasts and primografts revealed a migratory signature of NG2+ blasts. This study provides new insights on the biology of NG2 in iMLLr-B-ALL and suggests NG2 as a potential therapeutic target to reduce the risk of CNS disease/relapse and to provide safer CNS-directed therapies for iMLLr-B-ALL.

16 May 2013 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
EMEstefanía Martino‐Echarri
Estefanía Martino‐Echarri
RFRubén Fernández‐Rodríguez
Rubén Fernández‐Rodríguez
FRFrancisco Javier Rodríguez-Baena
Francisco Javier Rodríguez-Baena
ABAntonio Barrientos-Duran
Antonio Barrientos-Duran
ACANTONI XAVIER TORRES COLLADO
ANTONI XAVIER TORRES COLLADO
JRJuan Carlos Rodríguez-Manzaneque
Juan Carlos Rodríguez-Manzaneque

30 August 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FRFrancisco Javier Rodríguez-Baena
Francisco Javier Rodríguez-Baena
SGSilvia Redondo García
Silvia Redondo García
CPCarlos Peris-Torres
Carlos Peris-Torres
EMEstefanía Martino-Echarri
Estefanía Martino-Echarri
RFRubén Fernández-Rodríguez
Rubén Fernández-Rodríguez
JRJuan Carlos Rodríguez-Manzaneque
Juan Carlos Rodríguez-Manzaneque
Recent advances have emphasized the relevance of studying the extracellular microenvironment given its main contribution to tissue homeostasis and disease. Within this complex scenario, we have studied the extracellular protease ADAMTS1 (a disintegrin and metalloprotease with thrombospondin motif 1), implicated in vascularization and development, with reported anti- and pro-tumorigenic activities. In this work we performed a detailed study of the vasculature and substrates in adult organs of wild type and Adamts1-deficient mice. In addition to the expected alterations of organs like kidney, heart and aorta, we found that the lack of ADAMTS1 differently affects lymphocyte and myeloid populations in the spleen and bone marrow. The study of the substrate versican also revealed its alteration in the absence of the protease. With such premises, we challenged our mice with subcutaneous B16F1 syngeneic tumours and closely evaluated the immune repertoire in the tumours but also in the distant spleen and bone marrow. Our results confirmed a pro-inflammatory landscape in the absence of ADAMTS1, correlating with tumour blockade, supporting its novel role as a modulator of the immune cell response.